Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients

Publisher： Bentham Science Publishers

E-ISSN： 1875-5844|3|2|123-128

ISSN： 1567-2700

Source： Vascular Disease Prevention, Vol.3, Iss.2, 2006-05, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Consequences and Novel Therapy of Hyperphosphatemia: Lanthanum Carbonate for Dialysis Patients

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 29-34

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Adipokines in Hypertension and Cardiovascular Disease

By  

Current Hypertension Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 208-215

Bentham Science Publishers

Access to resources Recommend Favorite

Urocortins: Putative Role in Cardiovascular Disease

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 1, 2004-01 ,pp. : 43-47

Bentham Science Publishers

Access to resources Recommend Favorite

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Hyperglycaemia in Pathogenesis of Diabetic Cardiovascular Disease

By  

Vascular Disease Prevention, Vol. 4, Iss. 2, 2007-05 ,pp. : 125-139

Bentham Science Publishers

Access to resources Recommend Favorite